Genetically identical twin transplantation for chronic lymphocytic leukemia

Leukemia

Volumn 21, Issue 12, 2007, Pages 2452-2455

  Pavletic, S Z ^a   Zhou, G ^b   Sobocinski, K ^c   Marti, G ^d   Doney, K ^e   DiPersio, J ^f   Feremans, W ^g   Foroni, L ^h   Goodman, S ⁱ   Prentice, G ^h   LeMaistre, C ^j   Bandini, G ^k   Ferrant, A ^l   Jacobsen, N ^m   Khouri, I ⁿ   Gale, R P ^c   Wiestner, A ^o   Giralt, S ⁿ   Montserrat, E ^p   Chan, W C ^b   Bredeson, C ^c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ERASME HOSPITAL   (Belgium)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^j TEXAS TRANSPLANT INSTITUTE   (United States)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^m Rigshospitalet   (Denmark)

ⁿ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^o NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^p UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER CONTROL; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; MONOZYGOTIC TWINS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL TIME; TREATMENT OUTCOME; VERTICAL TRANSMISSION; WHOLE BODY RADIATION;

EID: 36348930433     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404928     Document Type: Article

References (29)

1. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646-652.
2. Gahrton G, Svensson H, Bjorkstrand B, Apperley J, Carlson K, Cavo M et al. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European group for blood and marrow transplantation. Bone Marrow Transplant 1999; 24: 741-745.
3. Barrett AJ, Ringden O, Zhang MJ, Bashey A, Cahn JY, Cairo MS et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000; 95: 3323-3327.
4. Bierman PJ, Sweetenham JW, Loberiza Jr FR, Taghipour G, Lazarus HM, Rizzo JD et al. Syngeneic hematopoietic stem-cell transplantation for non-hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - the Lymphoma working committee of the international bone marrow transplant registry and the European group for blood and marrow transplantation. J Clin Oncol 2003; 21: 3744-3753.
5. Kroger N, Brand R, van Biezen A, Bron D, Blaise D, Hellstrom-Lindberg E et al. Stem cell transplantation from identical twins in patients with myelodysplastic syndromes. Bone Marrow Transplant 2005; 35 37-43.
6. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
7. Khouri IF, Kantarjian HM, Talpaz M, Giralt S, Rios MO, Hester JP et al. Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience. Bone Marrow Transplant 1996; 17: 775-779.
8. Kanfer EJ, Buckner CD, Fefer A, Storb R, Appelbaum FR, Hill RS et al. Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation. Bone Marrow Transplant 1987; 1: 339-346.
9. Ritgen M, Stilgenbauer S, von Neuhoff N, Humpe A, Bruggemann M, Pott C et al. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: Implications of minimal residual disease measurement with quantitative PCR. Blood 2004; 104: 2600-2602.
10. Moreno C, Villamor N, Colomer D, Esteve J, Martino R, Nomdedeu J et al. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3433-3438.
11. Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR et al. Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: Results from the center for international blood and marrow transplant research. J Clin Oncol 2005; 23: 5788-5794.
12. Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J et al. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: The cooperative German transplant study group. J Clin Oncol 2003; 21: 2747-2753.
13. Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3819-3829.
14. Pavletic ZS, Bierman PJ, Vose JM, Bishop MR, Wu CD, Pierson JL et al. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Ann Oncol 1998; 9: 1023-1026.
15. Gribben JG, Zahrieh D, Stephans K, Bartlett-Pandite L, Alyea EP, Fisher DC et al. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood 2005; 106: 4389-4396.
16. Esteve J, Villamor N, Colomer D, Cervantes F, Campo E, Carreras E et al. Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status. Leukemia 2001; 15: 445-451.
17. Wu GQ, Sharp JG, Wu G, Vose J, Greiner TC, Chan WC. The detection of minimal lymphoma by molecular and combined culture-molecular methods. Br J Haematol 1997; 99: 873-881.
18. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S et al. National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
19. Montserrat E, Moreno C, Esteve J, Urbano-Ispizua A, Gine E, Bosch F. How I treat refractory CLL? Blood 2006; 107: 1276-1283.
20. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
21. Aoun P, Zhou G, Chan WC, Page C, Neth K, Pickering D et al. Familial B-cell chronic lymphocytic leukemia: Analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. Am J Clin Pathol 2007; 127: 31-38.
22. Brok-Simoni F, Rechavi G, Katzir N, Ben-Bassat I. Chronic lymphocytic leukaemia in twin sisters: Monozygous but not identical. Lancet 1987; 1: 329-330.
23. Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002; 100: 2289-2290.
24. Marti GE, Carter P, Abbasi F, Washington GC, Jain N, Zenger VE et al. B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom 2003; 52: 1-12.
25. Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA et al. Monoclonal B lymphocytes with the characteristics of 'indolent' chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635-639.
26. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337-2342.
27. Niederwieser D, Gentilini C, Hegenbart U, Lange T, Moosmann P, Ponisch W et al. Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant 2004; 34: 657-665.
28. Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 511-517.
29. Kiss TL, Chang H, Daly A, Messner HA, Jamal N, Spaner D et al. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals. Bone Marrow Transplant 2004; 33: 855-858.